510(k) Report

510(k) · Cleared

Cleared

Béa Applicator (BAP-GB-01)

K242031510(k) TraditionalCleared Apr 2, 2025265-day reviewClass II21 CFR 884.5250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Stepone Fertility Ltd (T/A Béa Fertility) · HDR Cap, Cervical

Cleared on Apr 2, 2025 as substantially equivalent to K222969 (Rosesta Medical BV, 2023) after a 265-day review. Its family tree reaches back 2 generations to 2000.

Decided
Apr 2, 2025
Review
265 days
Class
Class II
Product code
HDR
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K993953 (2000). No later device cites it as a predicate yet.

  1. Root · 2 generations backK993953 Oves Cervical CapVeos, Ltd. · 2000
  2. 1 generation backK222969 FERTI-LILY Conception CupRosesta Medical BV · 2023
  3. This deviceK242031 Béa Applicator (BAP-GB-01)Stepone Fertility Ltd (T/A Béa Fertility) · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K993953Oves Cervical CapVeos, Ltd.2000—
−1K222969FERTI-LILY Conception CupRosesta Medical BV2023—
0 (this device)K242031Béa Applicator (BAP-GB-01)Stepone Fertility Ltd (T/A Béa Fertility)2025—
FIG. 1 — Lineage of K242031, 2000–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HDR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HDR device

  1. #1 K222969 FERTI-LILY Conception Cupscore 8.6 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K222969FERTI-LILY Conception Cup
Summary page 5
…: Class II 4. Predicate Device Information Device Name: FERTI.LILY Conception Cup 510(k) Number: K222969 Sponsor: Rosesta Medical BV The predicate device has not been subject to a design-related reca…
Rosesta Medical BV2023—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 25 years and passes through 3 companies; a new generation was cleared every 23.3 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All HDR devices

HDR Cap, Cervical: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · HDR

1in 2025

2023: 12025: 1
2007high 1 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HDR

Too few HDR 510(k)s in any year since 2007 to give a median.

Recalls per year · HDR

No recall names HDR since 2007.

Adverse event reports per year · HDR

1in 2014

2014: 1
2007high 1 (2014) · low 0 (2007)2025

MAUDE reports naming product code HDR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—01
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20231—00
20240—00
20251—00
20260—0—

What is it indicated for?

The Béa Applicator is indicated for over-the-counter home use by couples who have been unable to conceive naturally and who have received a diagnosis of low sperm count, sperm immobility or unfavorable vaginal environment. The Béa Applicator contains a Béa Cervical Cap which is used to contain, deliver, and retain semen near the cervical opening as an aid to conception. The Béa Applicator should be used during the ovulatory phase of the menstrual cycle. The Béa Cervical Cap should not be left in place for longer than 5 hours.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K242031: Béa Applicator (BAP-GB-01).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K242031

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026